Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Spellberg

Showing results (101-110 of 267) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|November 27, 2024
Endocarditis Therapy: The Move From Expert Opinion to EvidenceBrad Spellberg, Todd C Lee, Bassam Ghanem, et al.
Population Health Management|August 23, 2013
Impact of hospital variables on case mix index as a marker of disease severityCarmen M Mendez, Darrell W Harrington, Peter Christenson, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2022
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts <i>In Vivo</i> Outcomes in Galleria mellonellaSarah Miller, Kristine Goy, Rosemary She, et al.
Annals of Internal Medicine|November 16, 2021
The Future of Medical Guidelines: Standardizing Clinical Care With the Humility of UncertaintyBrad Spellberg, William F Wright, Terry Shaneyfelt, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic miceBrad Spellberg, Yue Fu, John E Edwards, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzaeAshraf S Ibrahim, Valentina Avanessian, Brad Spellberg, et al.
Medical Mycology|September 18, 2008
Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?Ashraf S Ibrahim, John E Edwards, Richard Bryant, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 2006
Deferiprone iron chelation as a novel therapy for experimental mucormycosisAshraf S Ibrahim, John E Edwards, Yue Fu, et al.
Annals of Emergency Medicine|January 22, 2011
To treat or not to treat: adjunctive antibiotics for uncomplicated abscessesBrad Spellberg, Helen Boucher, John Bradley, et al.
Clinical Investigation|September 20, 2011
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumoniaBrad Spellberg, Roger J Lewis, Helen W Boucher, et al.
Pageof 27

Showing results (101-110 of 267) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|November 27, 2024
Endocarditis Therapy: The Move From Expert Opinion to EvidenceBrad Spellberg, Todd C Lee, Bassam Ghanem, et al.
Population Health Management|August 23, 2013
Impact of hospital variables on case mix index as a marker of disease severityCarmen M Mendez, Darrell W Harrington, Peter Christenson, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2022
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts <i>In Vivo</i> Outcomes in Galleria mellonellaSarah Miller, Kristine Goy, Rosemary She, et al.
Annals of Internal Medicine|November 16, 2021
The Future of Medical Guidelines: Standardizing Clinical Care With the Humility of UncertaintyBrad Spellberg, William F Wright, Terry Shaneyfelt, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic miceBrad Spellberg, Yue Fu, John E Edwards, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzaeAshraf S Ibrahim, Valentina Avanessian, Brad Spellberg, et al.
Medical Mycology|September 18, 2008
Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?Ashraf S Ibrahim, John E Edwards, Richard Bryant, et al.
The Journal of Antimicrobial Chemotherapy|August 25, 2006
Deferiprone iron chelation as a novel therapy for experimental mucormycosisAshraf S Ibrahim, John E Edwards, Yue Fu, et al.
Annals of Emergency Medicine|January 22, 2011
To treat or not to treat: adjunctive antibiotics for uncomplicated abscessesBrad Spellberg, Helen Boucher, John Bradley, et al.
Clinical Investigation|September 20, 2011
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumoniaBrad Spellberg, Roger J Lewis, Helen W Boucher, et al.
Pageof 27